MLchartDataset catalogue

Doravirine

Term · Oncology and biomedicine · MLC-T-ONC-013147

A pyridinone non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1), that is used to treat HIV infection. Upon oral administration, doravirine non-competitively inhibits HIV-1 reverse transcriptase (RT), thereby inhibiting HIV-1 viral replication.

Table 1. Record
IdentifierMLC-T-ONC-013147
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-013147",
  "term": "Doravirine",
  "field": "Oncology and biomedicine",
  "definition": "A pyridinone non-nucleoside reverse transcriptase inhibitor (NNRTI) of human immunodeficiency virus type 1 (HIV-1), that is used to treat HIV infection. Upon oral administration, doravirine non-competitively inhibits HIV-1 reverse transcriptase (RT), thereby inhibiting HIV-1 viral replication.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/doravirine/"
}

Record 6,181 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.